{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:11:41Z","timestamp":1780510301774,"version":"3.54.1"},"reference-count":7,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"11","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2019.242529","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T16:05:12Z","timestamp":1581609912000},"page":"2664-2666","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation"],"prefix":"10.3324","volume":"105","author":[{"family":"Guillaume Manson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Pauline Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Charles Herbaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kamal Bouabdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Chlo\u00e9 Antier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Florence Poizeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Laurent Dercle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Roch Houot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"14446","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-841262"},{"key":"14447","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761346"},{"key":"14448","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-749556"},{"key":"14449","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3585-9"},{"key":"14450","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3444-0"},{"key":"14451","unstructured":"Ansell SM, Armand P, Timmerman JM. Nivolumab re-treatment in patients with relapsed\/refractory Hodgkin lymphoma. Presented at the 11th International Symposium on Hodgkin Lymphoma. Abstract #0116, 2018 Cologne, Germany."},{"key":"14452","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000324"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/9654\/70583","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9654\/70584","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9654\/70583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T08:43:17Z","timestamp":1604306597000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/9654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":7,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2019.242529","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,13]]}}}